These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32925784)

  • 21. TNFRSF11B Suppresses Memory CD4+ T Cell Infiltration in the Colon Cancer Microenvironment: A Multiomics Integrative Analysis.
    Zhang JR; Hou P; Wang XJ; Weng ZQ; Shang-Guan XC; Wang H; You F; Lin BQ; Huang ZY; Chen XQ
    Front Immunol; 2021; 12():742358. PubMed ID: 34938284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of an Immune Gene Signature Based on Tumor Microenvironment Characteristics in Colon Adenocarcinoma.
    Chen Y; Zhao J
    Cell Transplant; 2021; 30():9636897211001314. PubMed ID: 33787354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
    Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma.
    Wu D; Xiang L; Peng L; Gu H; Tang Y; Luo H; Liu H; Wang Y
    PLoS One; 2022; 17(10):e0276430. PubMed ID: 36264920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration.
    Cao Z; Lin J; Fu G; Niu L; Yang Z; Cai W
    Front Immunol; 2022; 13():959967. PubMed ID: 36177002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-Associated Stromal Fibroblast-Derived Transcriptomes Predict Poor Clinical Outcomes and Immunosuppression in Colon Cancer.
    Wang J; Akter R; Shahriar MF; Uddin MN
    Pathol Oncol Res; 2022; 28():1610350. PubMed ID: 35991839
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic Biomarker SLCO4A1 Is Correlated with Tumor Immune Infiltration in Colon Adenocarcinoma.
    Chen X; Yi G; Zhou Y; Hu W; Xi L; Han W; Wang F
    Mediators Inflamm; 2023; 2023():4926474. PubMed ID: 37124063
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
    Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. INSC Is a Prognosis-Associated Biomarker Involved in Tumor Immune Infiltration in Colon Adenocarcinoma.
    Zhaoran S; Weidong J
    Biomed Res Int; 2022; 2022():5794150. PubMed ID: 36132082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PD-L1+ dendritic cells in the tumor microenvironment correlate with good prognosis and CD8+ T cell infiltration in colon cancer.
    Miller TJ; Anyaegbu CC; Lee-Pullen TF; Spalding LJ; Platell CF; McCoy MJ
    Cancer Sci; 2021 Mar; 112(3):1173-1183. PubMed ID: 33345422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune-related genes in tumor-specific CD4
    Yang X; Wu W; Pan Y; Zhou Q; Xu J; Han S
    BMC Cancer; 2020 Jun; 20(1):585. PubMed ID: 32571262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis.
    Luo J; Liu P; Wang L; Huang Y; Wang Y; Geng W; Chen D; Bai Y; Yang Z
    BMC Cancer; 2020 Nov; 20(1):1071. PubMed ID: 33167940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
    Wang W; Ren S; Wang Z; Zhang C; Huang J
    Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognosis poor, immune infiltration of colon adenocarcinoma associated with low expression levels of calcium-activated chloride channel.
    Zhao X; Chen Y; Wang L; Sui D; Lu J
    Pol J Pathol; 2024; 75(2):138-152. PubMed ID: 39166522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.
    Li X; Wen D; Li X; Yao C; Chong W; Chen H
    Front Immunol; 2020; 11():1678. PubMed ID: 33013820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PLOD3 Is Associated with Immune Cell Infiltration and Genomic Instability in Colon Adenocarcinoma.
    Deng X; Pan Y; Yang M; Liu Y; Li J
    Biomed Res Int; 2021; 2021():4714526. PubMed ID: 34239923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma.
    Meng C; Zhang Y; Jiang D; Wang J
    World J Surg Oncol; 2022 Mar; 20(1):89. PubMed ID: 35307012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer.
    Kießler M; Plesca I; Sommer U; Wehner R; Wilczkowski F; Müller L; Tunger A; Lai X; Rentsch A; Peuker K; Zeissig S; Seifert AM; Seifert L; Weitz J; Bachmann M; Bornhäuser M; Aust D; Baretton G; Schmitz M
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.